WO2002013793A3 - Method of making tablets and tablet compositions produced therefrom - Google Patents

Method of making tablets and tablet compositions produced therefrom Download PDF

Info

Publication number
WO2002013793A3
WO2002013793A3 PCT/US2001/020965 US0120965W WO0213793A3 WO 2002013793 A3 WO2002013793 A3 WO 2002013793A3 US 0120965 W US0120965 W US 0120965W WO 0213793 A3 WO0213793 A3 WO 0213793A3
Authority
WO
WIPO (PCT)
Prior art keywords
tablet compositions
compositions produced
produced therefrom
therapeutic compound
present
Prior art date
Application number
PCT/US2001/020965
Other languages
French (fr)
Other versions
WO2002013793A2 (en
Inventor
William J Mergens
Kuei Tu Chang
Gerald T Holly
Original Assignee
Rexall Sundown Inc
William J Mergens
Kuei Tu Chang
Gerald T Holly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rexall Sundown Inc, William J Mergens, Kuei Tu Chang, Gerald T Holly filed Critical Rexall Sundown Inc
Priority to BR0113305-5A priority Critical patent/BR0113305A/en
Priority to EP01952362A priority patent/EP1309314A2/en
Priority to JP2002518940A priority patent/JP2004506007A/en
Priority to AU2001273122A priority patent/AU2001273122A1/en
Publication of WO2002013793A2 publication Critical patent/WO2002013793A2/en
Publication of WO2002013793A3 publication Critical patent/WO2002013793A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

The present invention provides a method of making tablet compositions that are substantially free of excipients. The method includes forming a compactable granular mixture containing at least one compaction enhancing therapeutic compound, at least one other therapeutic compound that is different form the compaction enhancing therapeutic compound, and less than about 15 weight percent of a non-aesthetic excipient. The compactable granular mixture thus obtained is compressed to form a tablet composition. The present invention also provides tablet compositions produced by the methods of the present invention that are substantially free of excipients.
PCT/US2001/020965 2000-08-16 2001-07-02 Method of making tablets and tablet compositions produced therefrom WO2002013793A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BR0113305-5A BR0113305A (en) 2000-08-16 2001-07-02 Method for producing a tablet composition, tablet, method for producing a tablet, and tablet composition
EP01952362A EP1309314A2 (en) 2000-08-16 2001-07-02 Method of making tablets and tablet compositions produced therefrom
JP2002518940A JP2004506007A (en) 2000-08-16 2001-07-02 Method for producing tablets and tablet composition made therefrom
AU2001273122A AU2001273122A1 (en) 2000-08-16 2001-07-02 Method of making tablets and tablet compositions produced therefrom

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/639,780 2000-08-16
US09/639,780 US6358526B1 (en) 2000-08-16 2000-08-16 Method of making tablets and tablet compositions produced therefrom

Publications (2)

Publication Number Publication Date
WO2002013793A2 WO2002013793A2 (en) 2002-02-21
WO2002013793A3 true WO2002013793A3 (en) 2002-08-15

Family

ID=24565509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020965 WO2002013793A2 (en) 2000-08-16 2001-07-02 Method of making tablets and tablet compositions produced therefrom

Country Status (7)

Country Link
US (2) US6358526B1 (en)
EP (1) EP1309314A2 (en)
JP (1) JP2004506007A (en)
AU (1) AU2001273122A1 (en)
BR (1) BR0113305A (en)
CA (1) CA2354639A1 (en)
WO (1) WO2002013793A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1411986B1 (en) * 2001-07-30 2008-03-12 DSM IP Assets B.V. Composition comprising epigallocatechin gallate
AT503510A1 (en) * 2001-10-16 2007-10-15 Dsm Fine Chem Austria Gmbh METHOD AND DEVICE FOR DEFINED CUTTING OF POLYMERISAT JOINTS
US6713096B2 (en) * 2002-01-04 2004-03-30 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
KR20030078105A (en) * 2002-03-28 2003-10-08 (주)다산메디켐 The novel composition of excipient for solid dosage form
US6660308B1 (en) 2002-09-11 2003-12-09 Kenneth A. Martin Beverage and additive for the ill
US20040253227A1 (en) * 2002-09-11 2004-12-16 Martin Kenneth A. Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery
US20040254095A1 (en) * 2002-09-11 2004-12-16 Martin Kenneth A. Supplement for treating musculoskeletal disorders
US20040253296A1 (en) * 2002-09-11 2004-12-16 Martin Kenneth A. Food bar for treating musculoskeletal disorders
US6900173B2 (en) * 2002-09-11 2005-05-31 Kenneth A. Martin Perioperative multivitamin protein bar for use in preparing an individual for fast surgical recovery
DE10248652A1 (en) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Process for the production of dust-free alkaline earth peroxides
FR2858556B1 (en) * 2003-08-06 2006-03-10 Galenix Innovations DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
CA2543458A1 (en) * 2003-10-24 2005-05-12 Josef Rettenmaier & Soehne Gmbh & Co., Kg Process for co-spray drying agents with dry silicified mcc
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
AU2005237550B2 (en) 2004-04-28 2010-09-23 Nutrition Science Partners Limited Crude extracts from andrographis paniculata
US20070248666A1 (en) * 2004-06-30 2007-10-25 Rijkers Marinus Petrus W M Granules Comprising a Beta-Lactam Antibiotic
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
US7871573B2 (en) * 2004-07-26 2011-01-18 University Of Louisville Research Foundation, Inc. Enhancement of sensitivity of fluorophore mediated biosensing and bioimaging
US20060039972A1 (en) * 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including a grape-derived component
US20060083837A1 (en) * 2004-10-18 2006-04-20 Monfre John G Aspartame blend
US20060105989A1 (en) * 2004-11-18 2006-05-18 Kinya Takagaki Food for improving arthritis
TWI354559B (en) * 2004-12-27 2011-12-21 Yaizu Suisankagaku Ind Co Ltd Oral disintegrative n-acetylglucosamine tablet and
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US7351853B2 (en) * 2006-01-23 2008-04-01 Albion Advanced Nutrition Method of manufacturing a granular mineral composition
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
JP2007238486A (en) * 2006-03-07 2007-09-20 Yaizu Suisankagaku Industry Co Ltd Method for producing tablet containing glucosamine, glucosamine-containing tablet and glucosamine-containing granule
US8388750B2 (en) * 2007-03-21 2013-03-05 Imerys Pigments, Inc. Granulated kaolin compositions and processes for their production
US20080311246A1 (en) * 2007-06-18 2008-12-18 Byproduct Feed Technologies Llc Method of producing ruminant-edible feed products
FR2918376B1 (en) * 2007-07-04 2011-10-28 Mathieu Borge LIQUID OR PASSIZED COMPOSITIONS FOR THE CONTRIBUTION OF ESSENTIAL ELEMENTS TO THE SYNTHESIS AND CONSTITUTION OF PROTEOGLYCANS, IN PARTICULAR FOR THE TREATMENT OF CARTILAGE DEGRADATION
ITPD20070274A1 (en) * 2007-08-08 2009-02-09 Sanypet S P A CROCCHETTA FOR ANIMALS AND METHOD FOR ITS PRODUCTION
US7695747B2 (en) * 2007-09-17 2010-04-13 Russell Meier Method of producing dried distillers grain agglomerated particles
US20090117209A1 (en) 2007-11-02 2009-05-07 Hutchison Medipharma Enterprises Limited Andrographis paniculata extract
TWI468167B (en) 2007-11-16 2015-01-11 威佛（國際）股份有限公司 Pharmaceutical compositions
KR20100099260A (en) * 2007-12-12 2010-09-10 디에스엠 아이피 어셋츠 비.브이. Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
US20110318436A1 (en) * 2008-07-09 2011-12-29 Himalaya Global Holdings Ltd Herbal solid formulation and process for preparing the same
BRPI0918499A2 (en) * 2008-09-02 2015-12-01 Usv Ltd cross-linked polymers
ITTV20090026A1 (en) * 2009-02-24 2010-08-25 Labomar S R L METHOD FOR THE PRODUCTION OF A HYDRO-DISPERSIBLE SOLID COMPOSITION OF INSULUBLE SUBSTRATES AND COMPOSITION OBTAINED THROUGH THIS METHOD.
WO2010141191A1 (en) * 2009-05-13 2010-12-09 Wyeth Llc Method to stabilize a dietary supplement comprising glucosamine
US9352008B2 (en) * 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
LT3168308T (en) * 2009-10-14 2018-05-10 Xyleco, Inc. Producing edible residues from ethanol production
US20110091618A1 (en) * 2009-10-16 2011-04-21 Frito-Lay North America, Inc. Method for preventing oxidation and off flavors in high carotenoid foods
FR2968215B1 (en) * 2010-12-02 2013-08-23 Laetitia Mathez COMPOSITION COMPRISING A CHONDROPROTECTIVE ELEMENT AND VITAMINS
AR089857A1 (en) * 2012-02-02 2014-09-24 Glaxosmithkline Llc COMPRESSED ANTICIDE TO COOL THE BREATH
CA2931173C (en) 2013-11-27 2018-10-09 Vifor (International) Ag Pharmaceutical composition, comprising phosphate binder particles
EP3137061A1 (en) * 2014-04-30 2017-03-08 Acino Supply AG Method and device for producing a pharmaceutical composition
CN105963317A (en) * 2016-05-05 2016-09-28 南京素德问医药科技有限公司 Pharmaceutical composition having function of improving bone density
KR102231289B1 (en) * 2018-12-26 2021-03-23 (주)휴온스 High Content Chondroitin Sulfate Pharmaceutical Formulation and Manufacturing Method Thereof
CN112515026A (en) * 2019-09-18 2021-03-19 李宗刚 Ginseng small-molecule peptide tablet candy and purification preparation process

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000852A1 (en) * 1987-07-29 1989-02-09 The Upjohn Company Controlled release of antibiotic salts from an implant
US5635208A (en) * 1993-07-20 1997-06-03 Mcneil-Ppc, Inc. Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same
WO1997033564A1 (en) * 1996-03-13 1997-09-18 Biochemie Gesellschaft Mbh Agglomerates containing beta-lactam compounds
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
US5866166A (en) * 1995-01-09 1999-02-02 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073380A (en) 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5372823A (en) 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
DE3927810A1 (en) * 1989-08-23 1991-02-28 Basf Ag RIBOFLAVING RANULATES
NZ239802A (en) 1990-09-21 1993-09-27 Merrell Dow Pharma A superior tasting pharmaceutical composition having porous particles produced through in situ gas generation and a process for its production
SK282072B6 (en) 1991-01-30 2001-10-08 The Wellcome Foundation Limited Water-dispersible tablet containing lamotrigine and its preparation method
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
IT1264530B (en) 1992-07-31 1996-10-02 Crinos Industria Farmaco USE OF POLYSACCHARIDES IN ATROPHIC DEGENERATIVE NEUROPATHIES
US5422122A (en) 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
CZ289133B6 (en) 1995-06-22 2001-11-14 Akzo Nobel N. V. Compressed dry-granulation tablets or granules and process for producing thereof
US5840715A (en) 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5948437A (en) 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5804594A (en) 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US5849336A (en) 1997-07-02 1998-12-15 Abbott Laboratories Method using sturgeon notochord for alleviating the symptoms of arthritis
WO1999004758A1 (en) * 1997-07-25 1999-02-04 Elan Corporation Plc A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
SI0951909T2 (en) * 1998-03-19 2010-11-30 Sigma Tau Ind Farmaceuti Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
WO1999062524A1 (en) * 1998-06-04 1999-12-09 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000852A1 (en) * 1987-07-29 1989-02-09 The Upjohn Company Controlled release of antibiotic salts from an implant
US5635208A (en) * 1993-07-20 1997-06-03 Mcneil-Ppc, Inc. Granulation process for producing an acetaminophen and diphenhydramine hydrochloride composition and composition produced by same
US5866166A (en) * 1995-01-09 1999-02-02 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
WO1997033564A1 (en) * 1996-03-13 1997-09-18 Biochemie Gesellschaft Mbh Agglomerates containing beta-lactam compounds
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis

Also Published As

Publication number Publication date
US20020150617A1 (en) 2002-10-17
US6358526B1 (en) 2002-03-19
EP1309314A2 (en) 2003-05-14
AU2001273122A1 (en) 2002-02-25
BR0113305A (en) 2003-07-15
CA2354639A1 (en) 2002-02-16
JP2004506007A (en) 2004-02-26
WO2002013793A2 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
WO2002013793A3 (en) Method of making tablets and tablet compositions produced therefrom
RU2004123624A (en) DRY GRANULATED AZITHROMYCIN COMPOSITIONS
US6113944A (en) Paroxetine tablets and process to prepare them
CA2311734A1 (en) Flash-melt oral dosage formulation
EP0151344A3 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
NO20061347L (en) Pharmaceutical formulation comprising lanthanum compounds
MY128046A (en) Rapidly disintegrating methylcellulose tablets
UA70926C2 (en) Rapidly disintegrating tablets (variants) and method for their manufacture
AU2001236207A1 (en) Powder formulation
AU8977698A (en) A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
MXPA04003027A (en) Methods for wet granulating azithromycin.
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
AU5002499A (en) Controlled release polyacrylic acid granules and a process for preparing the same
CA2419314A1 (en) Preparation of risperidone
CA2300452A1 (en) Orally administrable solid ribavirin dosage forms and process for making them
EP0237241A3 (en) Calcium supplement compressed tablets
MY137846A (en) Processes for the preparation of oral dosage formulations of modafinil
MXPA04006071A (en) Process for production of detergent tablets.
ZA200308353B (en) Compaction process for manufacture of sodium phenytoin dosage form.
GR20010100377A (en) Pharmaceutical composition containing citalopram
CA2306508A1 (en) Production of a directly compressible tabletting aid
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
US6322812B1 (en) Pharmaceutical forms for the oral administration of mesna

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001273122

Country of ref document: AU

Ref document number: 2002518940

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001952362

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001952362

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001952362

Country of ref document: EP